The stock can work even if the market stops valuing it like a scarcity-era pure play. My case assumes CoreWeave matures into a scaled AI infrastructure provider with some software and
inference attachment: still differentiated, but valued more like a high-growth utility-plus-platform. Most upside comes from
backlog conversion and scale, not from another euphoric
rerating.